BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8617147)

  • 1. Pleuropericarditis related to the use of mesalamine.
    Gujral N; Friedenberg F; Friedenberg J; Gabriel G; Kotler M; Levine G
    Dig Dis Sci; 1996 Mar; 41(3):624-6. PubMed ID: 8617147
    [No Abstract]   [Full Text] [Related]  

  • 2. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
    Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
    Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
    Loizeau E
    Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature.
    Sentongo TA; Piccoli DA
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):344-7. PubMed ID: 9740210
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypersensitivity to 5-ASA suppositories.
    Borum ML; Ginsberg A
    Dig Dis Sci; 1997 May; 42(5):1076-8. PubMed ID: 9149065
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.
    Sviri S; Gafanovich I; Kramer MR; Tsvang E; Ben-Chetrit E
    J Clin Gastroenterol; 1997 Jan; 24(1):34-6. PubMed ID: 9013348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukopenia and thrombocytopenia as adverse effects of treatment with 5-aminosalicylic suppositories.
    Casellas F; Vallano A; Malagelada JR
    J Clin Gastroenterol; 1996 Mar; 22(2):160-1. PubMed ID: 8742664
    [No Abstract]   [Full Text] [Related]  

  • 8. [Peripheral eosinophilia in ulcerative colitis: apropos of a case].
    Galofre N; Fuste L; Oriol A; Grau J
    Gastroenterol Hepatol; 1997 Mar; 20(3):163. PubMed ID: 9162539
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune thrombocytopenia and ulcerative colitis: response to nonoperative therapy.
    McCaulley ME
    J Clin Gastroenterol; 1996 Oct; 23(3):242-3. PubMed ID: 8899515
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-aminosalicylates in inflammatory bowel disease--the more the merrier?
    Forbes A
    Eur J Gastroenterol Hepatol; 1995 Nov; 7(11):1017-9. PubMed ID: 8680898
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug points: Hypersensitivity reaction to balsalazide.
    Adhiyaman V; Vaishnavi A; Froese S
    BMJ; 2001 Sep; 323(7311):489. PubMed ID: 11532843
    [No Abstract]   [Full Text] [Related]  

  • 12. Exacerbation of chronic ulcerative colitis with mesalamine.
    Sturgeon JB; Bhatia P; Hermens D; Miner PB
    Gastroenterology; 1995 Jun; 108(6):1889-93. PubMed ID: 7768395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
    Niv Y
    Isr J Med Sci; 1987 Nov; 23(11):1161-3. PubMed ID: 3436802
    [No Abstract]   [Full Text] [Related]  

  • 14. Folliculitis and mesalamine.
    Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P
    Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969
    [No Abstract]   [Full Text] [Related]  

  • 15. Mesalamine-induced lung disease.
    Lázaro MT; García-Tejero MT; Díaz-Lobato S
    Arch Intern Med; 1997 Feb; 157(4):462. PubMed ID: 9046901
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfasalazine-induced pericarditis in a patient with ulcerative colitis without recurrence when switching to mesalazine.
    Perrot S; Aslangul E; Szwebel T; Gadhoum H; Romnicianu S; Le Jeunne C
    Int J Colorectal Dis; 2007 Sep; 22(9):1119-21. PubMed ID: 17440739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
    Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral balsalazide (Colazal) for ulcerative colitis.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):62-3. PubMed ID: 11468602
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis.
    Fornaciari G; Maccari S; Borgatti PP; Rustichelli R; Amelio N; Lattuada I; Plancher AC
    J Clin Gastroenterol; 1997 Jan; 24(1):37-9. PubMed ID: 9013349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mesalazine-induced acute pericarditis].
    Sierra Ausín M; Rascarachi G; Díez Rodríguez R; Arias Rodríguez L; Del Pozo Maroto E; Muñoz Núñez F
    Gastroenterol Hepatol; 2010 Apr; 33(4):338-9. PubMed ID: 20005014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.